These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 38018188)

  • 1. WITHDRAWN: Long-time-released Transdermal Microneedle Delivery System.
    Tang X; Qin H; Zhang X; Yang H; Yang J; Chen P; Jin Y; Yang L
    Curr Drug Deliv; 2023 Nov; ():. PubMed ID: 38018188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WITHDRAWN: The Ascension of Nanosponges as a Drug Delivery Carrier: Preparation, Characterization and Applications.
    Tiwari K; Bhattacharya S
    Curr Drug Deliv; 2022 Jun; ():. PubMed ID: 35713140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WITHDRAWN: Design and Evaluation of Floating Micro-Carriers for Effective Delivery of a Hydrophobic Drug.
    Hussain Z; Hongcai L; Ling Z; Nawaz MA; Naz AF; Yong W
    Curr Drug Deliv; 2022 May; ():. PubMed ID: 35578878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WITHDRAWN: Covid-19 Study, Pathology and Therapeutics.
    Lu DY
    Infect Disord Drug Targets; 2022 Feb; ():. PubMed ID: 35168512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WITHDRAWN: Pharmaceutical Nanoemulsion System: A Strategy to Enhance the Bioavailability of Drugs.
    Kumar S; Waliyan P; Pahwa R; Ali J; Baboota S; Sharma S; Hyder Pottoo F
    Curr Drug Metab; 2022 Jun; ():. PubMed ID: 35786182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Withdrawal Notice: Development of Itraconazole Loaded Transethosomes for Improved Transdermal Delivery.
    Mishra KK
    Recent Pat Nanotechnol; 2021 Nov; ():. PubMed ID: 34844550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WITHDRAWN: Application of Nanoparticles in the Management of Polycystic Ovary Syndrome.
    Al-Hetty HRAK; Saleh MM; Jalil AT
    Curr Drug Res Rev; 2023 Aug; ():. PubMed ID: 37592786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WITHDRAWN: Rap2A/p-ERK1/2 is Involved in Glioma Proliferation and Migration.
    Wang T; Wang J; Liang R; He J; Liao Q; Jiang Y
    Curr Mol Med; 2022 Aug; ():. PubMed ID: 35927807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WITHDRAWN: Original Antigenic Sin in COVID-19: Hoskins Effect and Vaccine.
    Khan M; Manzoor S; Ullah N; Khan D
    Infect Disord Drug Targets; 2022 Mar; ():. PubMed ID: 35301955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Withdrawal Notice: Circulatory Cells as Tumortropic Carrier for Targetability Improvement.
    Zou D; Weng Y; Yang P
    Curr Drug Deliv; 2020 Nov; ():. PubMed ID: 33234105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Withdrawal Notice: Atrial Fibrillation and Hypertension: “Quo Vadis”.
    Walker M; Patel P; Kwon O; Koene RJ; Duprez DA; Kwon Y
    Curr Hypertens Rev; 2019 May; ():. PubMed ID: 31057122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WITHDRAWN: Cannabis Sativa In Phytotherapy : Reappraisal Of Therapeutic Potential And Regulatory Aspects.
    Gupta P; Singh A; Shafi S; Ralli T; Pottoo FH; Kohli K
    Curr Pharm Biotechnol; 2022 Oct; ():. PubMed ID: 36281862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Withdrawn: A Review of Current Evidence from Cardiovascular Manifestations and Outcomes in Patients with COVID-19.
    Saberianpour S; Aleebrahim-Dehkordi E; Mazaheri E; Hasanpour-Dehkordi A
    Curr Pharm Des; 2022 Jul; ():. PubMed ID: 35838212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Withdrawn: Biomarkers in Disease Diagnosis and the Role of LC-MS and NMR: A Review.
    Ashaq I; Ahmad Sheikh A; Beri N; Mittal S; Javed Naim M; Alam O; Bawa S
    Curr Pharm Des; 2022 Apr; ():. PubMed ID: 35410591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Withdrawal Notice: Application of Nanomaterials in Development of Electrochemical Sensors and Drug Delivery Systems for Anticancer Drugs.
    Ghalkhani M; Kaya SI; Bakirhan NK; Ozkan Y; Ozkan SA
    Curr Drug Deliv; 2020 May; ():. PubMed ID: 32472999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WITHDRAWN: Obesity Paradox and Cardiovascular Diseases.
    Ganna I; Anna S
    Curr Cardiol Rev; 2022 May; ():. PubMed ID: 35570515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WITHDRAWN: Development, In Vitro and Ex-Vivo Assessment of CAP Liposomal Film for Dermal Delivery.
    Babu N; Beeravelli S; Murthy Kolapalli VR; Nimmathota M
    Recent Pat Nanotechnol; 2022 Feb; ():. PubMed ID: 35209831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WITHDRAWN: Computational Chemistry in the Fight Against SARSCoV-2.
    Khan A; Wei DQ
    Comb Chem High Throughput Screen; 2022 Jan; ():. PubMed ID: 35021969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Withdrawn: Camel FGF21 Protein Enhances FGF21 Signaling and its Targeted Compounds Screening.
    Gao Y; Yong F; Ji W; Zhang L; Hou J; Ma R; Zhao S; Ge H; Wu X
    Curr Pharm Des; 2024 Sep; ():. PubMed ID: 39350558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Withdrawal Notice: Investigation of the Use of Neural Networks for Diagnosing Breast Cancer on Mammograms.
    Ivanova GS; Golovkov AA; Petrova IS; Borodin AA; Shakhlan AO; Umnov AV; Lonshakova KA; Kelenin VV
    Curr Med Imaging; 2021 Jul; ():. PubMed ID: 34238166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.